Literature DB >> 25671465

Light-activated protein inhibition through photoinduced electron transfer of a ruthenium(II)-cobalt(III) bimetallic complex.

Robert J Holbrook1, David J Weinberg, Mark D Peterson, Emily A Weiss, Thomas J Meade.   

Abstract

We describe a mechanism of light activation that initiates protein inhibitory action of a biologically inert Co(III) Schiff base (Co(III)-sb) complex. Photoinduced electron transfer (PET) occurs from a Ru(II) bipyridal complex to a covalently attached Co(III) complex and is gated by conformational changes that occur in tens of nanoseconds. Reduction of the Co(III)-sb by PET initiates displacement of the inert axial imidazole ligands, promoting coordination to active site histidines of α-thrombin. Upon exposure to 455 nm light, the rate of ligand exchange with 4-methylimidazole, a histidine mimic, increases by approximately 5-fold, as observed by NMR spectroscopy. Similarly, the rate of α-thrombin inhibition increases over 5-fold upon irradiation. These results convey a strategy for light activation of inorganic therapeutic agents through PET utilizing redox-active metal centers.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25671465      PMCID: PMC4487626          DOI: 10.1021/jacs.5b00342

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  33 in total

1.  Control and utilization of ruthenium and rhodium metal complex excited states for photoactivated cancer therapy.

Authors:  Jessica D Knoll; Claudia Turro
Journal:  Coord Chem Rev       Date:  2015-01-01       Impact factor: 22.315

2.  Base pair motions control the rates and distance dependencies of reductive and oxidative DNA charge transfer.

Authors:  Linda Valis; Qiang Wang; Milen Raytchev; Ivan Buchvarov; Hans-Achim Wagenknecht; Torsten Fiebig
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-26       Impact factor: 11.205

3.  Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine.

Authors:  Nicola J Farrer; Luca Salassa; Peter J Sadler
Journal:  Dalton Trans       Date:  2009-11-11       Impact factor: 4.390

Review 4.  Metallodrugs in medicinal inorganic chemistry.

Authors:  Katja Dralle Mjos; Chris Orvig
Journal:  Chem Rev       Date:  2014-01-23       Impact factor: 60.622

5.  Coordination of hydroxyquinolines to a ruthenium bis-dimethyl-phenanthroline scaffold radically improves potency for potential as antineoplastic agents.

Authors:  David K Heidary; Brock S Howerton; Edith C Glazer
Journal:  J Med Chem       Date:  2014-11-03       Impact factor: 7.446

6.  Specific inhibition of the transcription factor Ci by a cobalt(III) Schiff base-DNA conjugate.

Authors:  Ryan R Hurtado; Allison S Harney; Marie C Heffern; Robert J Holbrook; Robert A Holmgren; Thomas J Meade
Journal:  Mol Pharm       Date:  2012-01-20       Impact factor: 4.939

7.  Inhibition of thermolysin and human alpha-thrombin by cobalt(III) Schiff base complexes.

Authors:  T Takeuchi; A Böttcher; C M Quezada; T J Meade; H B Gray
Journal:  Bioorg Med Chem       Date:  1999-05       Impact factor: 3.641

8.  Single-ion reorganization free energy of aqueous Ru(bpy)32+/3+ and Ru(H2O)62+/3+ from photoemission spectroscopy and density functional molecular dynamics simulation.

Authors:  Robert Seidel; Manfred Faubel; Bernd Winter; Jochen Blumberger
Journal:  J Am Chem Soc       Date:  2009-11-11       Impact factor: 15.419

9.  Rational design of [Co(acacen)L2]+ inhibitors of protein function.

Authors:  Lauren M Matosziuk; Robert J Holbrook; Lisa M Manus; Marie C Heffern; Mark A Ratner; Thomas J Meade
Journal:  Dalton Trans       Date:  2013-01-22       Impact factor: 4.390

10.  Photoinduced electron transfer from PbS quantum dots to cobalt(III) Schiff base complexes: light activation of a protein inhibitor.

Authors:  Mark D Peterson; Robert J Holbrook; Thomas J Meade; Emily A Weiss
Journal:  J Am Chem Soc       Date:  2013-08-23       Impact factor: 15.419

View more
  3 in total

1.  Physical properties, ligand substitution reactions, and biological activity of Co(iii)-Schiff base complexes.

Authors:  A Paden King; Hendryck A Gellineau; Samantha N MacMillan; Justin J Wilson
Journal:  Dalton Trans       Date:  2019-05-07       Impact factor: 4.390

2.  Tuning cobalt(III) Schiff base complexes as activated protein inhibitors.

Authors:  Marie C Heffern; Viktorie Reichova; Joseph L Coomes; Allison S Harney; Elizabeth A Bajema; Thomas J Meade
Journal:  Inorg Chem       Date:  2015-09-02       Impact factor: 5.165

Review 3.  Photofunctions in Hybrid Systems of Schiff Base Metal Complexes and Metal or Semiconductor (Nano)Materials.

Authors:  Takashiro Akitsu; Barbara Miroslaw; Shanmugavel Sudarsan
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.